1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hemophillia A and B Therapeutics Materials Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Desmopressin 1.2.3 Octocogalfa 1.2.4 Nonacogalfa 1.2.5 Others 1.3 Market by Application 1.3.1 Global Hemophillia A and B Therapeutics Materials Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Ambulatory Surgical Centers 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Hemophillia A and B Therapeutics Materials Market Perspective (2017-2028) 2.2 Hemophillia A and B Therapeutics Materials Growth Trends by Region 2.2.1 Hemophillia A and B Therapeutics Materials Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Hemophillia A and B Therapeutics Materials Historic Market Size by Region (2017-2022) 2.2.3 Hemophillia A and B Therapeutics Materials Forecasted Market Size by Region (2023-2028) 2.3 Hemophillia A and B Therapeutics Materials Market Dynamics 2.3.1 Hemophillia A and B Therapeutics Materials Industry Trends 2.3.2 Hemophillia A and B Therapeutics Materials Market Drivers 2.3.3 Hemophillia A and B Therapeutics Materials Market Challenges 2.3.4 Hemophillia A and B Therapeutics Materials Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hemophillia A and B Therapeutics Materials Players by Revenue 3.1.1 Global Top Hemophillia A and B Therapeutics Materials Players by Revenue (2017-2022) 3.1.2 Global Hemophillia A and B Therapeutics Materials Revenue Market Share by Players (2017-2022) 3.2 Global Hemophillia A and B Therapeutics Materials Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Hemophillia A and B Therapeutics Materials Revenue 3.4 Global Hemophillia A and B Therapeutics Materials Market Concentration Ratio 3.4.1 Global Hemophillia A and B Therapeutics Materials Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hemophillia A and B Therapeutics Materials Revenue in 2021 3.5 Hemophillia A and B Therapeutics Materials Key Players Head office and Area Served 3.6 Key Players Hemophillia A and B Therapeutics Materials Product Solution and Service 3.7 Date of Enter into Hemophillia A and B Therapeutics Materials Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hemophillia A and B Therapeutics Materials Breakdown Data by Type 4.1 Global Hemophillia A and B Therapeutics Materials Historic Market Size by Type (2017-2022) 4.2 Global Hemophillia A and B Therapeutics Materials Forecasted Market Size by Type (2023-2028) 5 Hemophillia A and B Therapeutics Materials Breakdown Data by Application 5.1 Global Hemophillia A and B Therapeutics Materials Historic Market Size by Application (2017-2022) 5.2 Global Hemophillia A and B Therapeutics Materials Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Hemophillia A and B Therapeutics Materials Market Size (2017-2028) 6.2 North America Hemophillia A and B Therapeutics Materials Market Size by Country (2017-2022) 6.3 North America Hemophillia A and B Therapeutics Materials Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Hemophillia A and B Therapeutics Materials Market Size (2017-2028) 7.2 Europe Hemophillia A and B Therapeutics Materials Market Size by Country (2017-2022) 7.3 Europe Hemophillia A and B Therapeutics Materials Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size (2017-2028) 8.2 Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size by Country (2017-2022) 8.3 Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Hemophillia A and B Therapeutics Materials Market Size (2017-2028) 9.2 Latin America Hemophillia A and B Therapeutics Materials Market Size by Country (2017-2022) 9.3 Latin America Hemophillia A and B Therapeutics Materials Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size (2017-2028) 10.2 Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Country (2017-2022) 10.3 Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Arsia therapeutics 11.1.1 Arsia therapeutics Company Detail 11.1.2 Arsia therapeutics Business Overview 11.1.3 Arsia therapeutics Hemophillia A and B Therapeutics Materials Introduction 11.1.4 Arsia therapeutics Revenue in Hemophillia A and B Therapeutics Materials Business (2017-2022) 11.1.5 Arsia therapeutics Recent Development 11.2 Spark Therapeutics, Inc. 11.2.1 Spark Therapeutics, Inc. Company Detail 11.2.2 Spark Therapeutics, Inc. Business Overview 11.2.3 Spark Therapeutics, Inc. Hemophillia A and B Therapeutics Materials Introduction 11.2.4 Spark Therapeutics, Inc. Revenue in Hemophillia A and B Therapeutics Materials Business (2017-2022) 11.2.5 Spark Therapeutics, Inc. Recent Development 11.3 Alnylam Pharmaceuticals, Inc. 11.3.1 Alnylam Pharmaceuticals, Inc. Company Detail 11.3.2 Alnylam Pharmaceuticals, Inc. Business Overview 11.3.3 Alnylam Pharmaceuticals, Inc. Hemophillia A and B Therapeutics Materials Introduction 11.3.4 Alnylam Pharmaceuticals, Inc. Revenue in Hemophillia A and B Therapeutics Materials Business (2017-2022) 11.3.5 Alnylam Pharmaceuticals, Inc. Recent Development 11.4 Sangamo Therapeutics, Inc. 11.4.1 Sangamo Therapeutics, Inc. Company Detail 11.4.2 Sangamo Therapeutics, Inc. Business Overview 11.4.3 Sangamo Therapeutics, Inc. Hemophillia A and B Therapeutics Materials Introduction 11.4.4 Sangamo Therapeutics, Inc. Revenue in Hemophillia A and B Therapeutics Materials Business (2017-2022) 11.4.5 Sangamo Therapeutics, Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Hemophillia A and B Therapeutics Materials Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Desmopressin Table 3. Key Players of Octocogalfa Table 4. Key Players of Nonacogalfa Table 5. Key Players of Others Table 6. Global Hemophillia A and B Therapeutics Materials Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Hemophillia A and B Therapeutics Materials Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Hemophillia A and B Therapeutics Materials Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Hemophillia A and B Therapeutics Materials Market Share by Region (2017-2022) Table 10. Global Hemophillia A and B Therapeutics Materials Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Hemophillia A and B Therapeutics Materials Market Share by Region (2023-2028) Table 12. Hemophillia A and B Therapeutics Materials Market Trends Table 13. Hemophillia A and B Therapeutics Materials Market Drivers Table 14. Hemophillia A and B Therapeutics Materials Market Challenges Table 15. Hemophillia A and B Therapeutics Materials Market Restraints Table 16. Global Hemophillia A and B Therapeutics Materials Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Hemophillia A and B Therapeutics Materials Market Share by Players (2017-2022) Table 18. Global Top Hemophillia A and B Therapeutics Materials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophillia A and B Therapeutics Materials as of 2021) Table 19. Ranking of Global Top Hemophillia A and B Therapeutics Materials Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Hemophillia A and B Therapeutics Materials Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Hemophillia A and B Therapeutics Materials Product Solution and Service Table 23. Date of Enter into Hemophillia A and B Therapeutics Materials Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Hemophillia A and B Therapeutics Materials Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Hemophillia A and B Therapeutics Materials Revenue Market Share by Type (2017-2022) Table 27. Global Hemophillia A and B Therapeutics Materials Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Hemophillia A and B Therapeutics Materials Revenue Market Share by Type (2023-2028) Table 29. Global Hemophillia A and B Therapeutics Materials Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Hemophillia A and B Therapeutics Materials Revenue Market Share by Application (2017-2022) Table 31. Global Hemophillia A and B Therapeutics Materials Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Hemophillia A and B Therapeutics Materials Revenue Market Share by Application (2023-2028) Table 33. North America Hemophillia A and B Therapeutics Materials Market Size by Country (2017-2022) & (US$ Million) Table 34. North America Hemophillia A and B Therapeutics Materials Market Size by Country (2023-2028) & (US$ Million) Table 35. Europe Hemophillia A and B Therapeutics Materials Market Size by Country (2017-2022) & (US$ Million) Table 36. Europe Hemophillia A and B Therapeutics Materials Market Size by Country (2023-2028) & (US$ Million) Table 37. Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size by Region (2017-2022) & (US$ Million) Table 38. Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size by Region (2023-2028) & (US$ Million) Table 39. Latin America Hemophillia A and B Therapeutics Materials Market Size by Country (2017-2022) & (US$ Million) Table 40. Latin America Hemophillia A and B Therapeutics Materials Market Size by Country (2023-2028) & (US$ Million) Table 41. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Country (2017-2022) & (US$ Million) Table 42. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Country (2023-2028) & (US$ Million) Table 43. Arsia therapeutics Company Detail Table 44. Arsia therapeutics Business Overview Table 45. Arsia therapeutics Hemophillia A and B Therapeutics Materials Product Table 46. Arsia therapeutics Revenue in Hemophillia A and B Therapeutics Materials Business (2017-2022) & (US$ Million) Table 47. Arsia therapeutics Recent Development Table 48. Spark Therapeutics, Inc. Company Detail Table 49. Spark Therapeutics, Inc. Business Overview Table 50. Spark Therapeutics, Inc. Hemophillia A and B Therapeutics Materials Product Table 51. Spark Therapeutics, Inc. Revenue in Hemophillia A and B Therapeutics Materials Business (2017-2022) & (US$ Million) Table 52. Spark Therapeutics, Inc. Recent Development Table 53. Alnylam Pharmaceuticals, Inc. Company Detail Table 54. Alnylam Pharmaceuticals, Inc. Business Overview Table 55. Alnylam Pharmaceuticals, Inc. Hemophillia A and B Therapeutics Materials Product Table 56. Alnylam Pharmaceuticals, Inc. Revenue in Hemophillia A and B Therapeutics Materials Business (2017-2022) & (US$ Million) Table 57. Alnylam Pharmaceuticals, Inc. Recent Development Table 58. Sangamo Therapeutics, Inc. Company Detail Table 59. Sangamo Therapeutics, Inc. Business Overview Table 60. Sangamo Therapeutics, Inc. Hemophillia A and B Therapeutics Materials Product Table 61. Sangamo Therapeutics, Inc. Revenue in Hemophillia A and B Therapeutics Materials Business (2017-2022) & (US$ Million) Table 62. Sangamo Therapeutics, Inc. Recent Development Table 63. Research Programs/Design for This Report Table 64. Key Data Information from Secondary Sources Table 65. Key Data Information from Primary Sources List of Figures Figure 1. Global Hemophillia A and B Therapeutics Materials Market Share by Type: 2021 VS 2028 Figure 2. Desmopressin Features Figure 3. Octocogalfa Features Figure 4. Nonacogalfa Features Figure 5. Others Features Figure 6. Global Hemophillia A and B Therapeutics Materials Market Share by Application in 2021 & 2028 Figure 7. Hospitals Case Studies Figure 8. Ambulatory Surgical Centers Case Studies Figure 9. Hemophillia A and B Therapeutics Materials Report Years Considered Figure 10. Global Hemophillia A and B Therapeutics Materials Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Hemophillia A and B Therapeutics Materials Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Hemophillia A and B Therapeutics Materials Market Share by Region: 2021 VS 2028 Figure 13. Global Hemophillia A and B Therapeutics Materials Market Share by Players in 2021 Figure 14. Global Top Hemophillia A and B Therapeutics Materials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophillia A and B Therapeutics Materials as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Hemophillia A and B Therapeutics Materials Revenue in 2021 Figure 16. North America Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. North America Hemophillia A and B Therapeutics Materials Market Share by Country (2017-2028) Figure 18. United States Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Hemophillia A and B Therapeutics Materials Market Share by Country (2017-2028) Figure 22. Germany Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. France Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. U.K. Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Italy Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Russia Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Nordic Countries Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Hemophillia A and B Therapeutics Materials Market Share by Region (2017-2028) Figure 30. China Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Japan Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. South Korea Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Southeast Asia Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. India Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Australia Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Hemophillia A and B Therapeutics Materials Market Share by Country (2017-2028) Figure 38. Mexico Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Brazil Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Share by Country (2017-2028) Figure 42. Turkey Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Saudi Arabia Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Arsia therapeutics Revenue Growth Rate in Hemophillia A and B Therapeutics Materials Business (2017-2022) Figure 45. Spark Therapeutics, Inc. Revenue Growth Rate in Hemophillia A and B Therapeutics Materials Business (2017-2022) Figure 46. Alnylam Pharmaceuticals, Inc. Revenue Growth Rate in Hemophillia A and B Therapeutics Materials Business (2017-2022) Figure 47. Sangamo Therapeutics, Inc. Revenue Growth Rate in Hemophillia A and B Therapeutics Materials Business (2017-2022) Figure 48. Bottom-up and Top-down Approaches for This Report Figure 49. Data Triangulation Figure 50. Key Executives Interviewed

Arsia therapeutics Spark Therapeutics, Inc. Alnylam Pharmaceuticals, Inc. Sangamo Therapeutics, Inc.